Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protein Express is a Japanese biotechnology company specializing in the development and production of recombinant proteins and peptides. The company is widely recognized for its proprietary Brevibacillus Expression System, which enables high-yield, high-purity production of proteins that are often difficult to express in traditional systems like E. coli. Protein Express provides a range of contract research and manufacturing services, including gene synthesis, protein purification, and the development of diagnostic reagents. Their expertise supports drug discovery, diagnostic development, and academic research globally. The company also offers specialized services in silkworm-based protein expression and cell-free synthesis technologies. By leveraging its unique microbial platforms, Protein Express assists pharmaceutical and biotech partners in overcoming complex protein production challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protein Express.